ORR in patient subgroups. Subgroup analysis of investigator-assessed ORR per Lugano 2014 criteria. Data cutoff of 27 Jan 2025. BCL2, B-cell lymphoma 2; ECOG PS, Eastern Cooperative Oncology Group performance status; LDH, lactate dehydrogenase; PI3K, phosphoinositide 3-kinase; ULN, upper limit of normal.